🇺🇸 FDA
Patent

US 8637511

Aminopyrimidines useful as kinase inhibitors

granted A61PA61P19/08A61P25/28

Quick answer

US patent 8637511 (Aminopyrimidines useful as kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P19/08, A61P25/28, A61P27/14, A61P29/00